Patents Assigned to S-Cell Biosciences, Inc.
  • Method to treat inflammation
    Patent number: 8236323
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 7, 2012
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20110064691
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 17, 2011
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond BEARDSLEY, Anthony E. Maida, III
  • Methods to treat T-cell disorders using TISF
    Patent number: 7776818
    Abstract: T4 Immune Stimulating Factor (TISF) selectively induces aberrant T-cells to initiate apoptosis. TISF and peptides that are related to TISF (TISF peptides) are therefore useful for the treatment of disorders characterized by aberrant production, development, or activity of T-cells or other cells of hematopoietic origin. This invention relates to methods of using TISF or a TISF peptide to treat such conditions, compositions containing TISF or a TISF peptide for use in such treatments, and use of TISF or a TISF peptide for the manufacture of pharmaceuticals.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: August 17, 2010
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • METHOD TO TREAT INFLAMMATION
    Publication number: 20100144629
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Application
    Filed: February 13, 2008
    Publication date: June 10, 2010
    Applicant: S-CELL BIOSCIENCES, INC.
    Inventor: Terry Raymond Beardsley
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20080267913
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: May 23, 2008
    Publication date: October 30, 2008
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20070190025
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: March 27, 2007
    Publication date: August 16, 2007
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Beardsley, Anthony Maida
  • Method to enhance hematopoiesis
    Patent number: 7196060
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: March 27, 2007
    Assignee: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida, III